Disparities in lung cancer treatment may point to an access problem. Less than 62% of lung cancer patients in the U.S. receive treatments recommended by the National Comprehensive Cancer Network (NCCN) guidelines.
It’s important to recognize that an R&D organization must use its resources to maximize the return on a company’s investment. To do that, investments must be made in therapeutic areas where the odds of technical, regulatory and commercial success are h…
Though two partnerships Walgreens has to strengthen the drugstore chain’s relationships with physicians remain in testing stages, company executives say they are performing well and a future expansion could be around the corner.
Of all of the 2020 candidates for President, only Biden, Bloomberg and Buttigieg have health care plans that have a realistic chance of becoming law––and fixing the health insurance system
Theoretically ACOs are “built” to manage patients on the care continuum to ensure that care is coordinated to deliver quality outcomes and better, lower-cost care.
An Ohio-based biopharmaceutical startup that’s developing new interventions for acute and chronic lung diseases – including for very preterm infants – has closed a $15.5 million oversubscribed Series C financing round.
It’s only about a week into the new decade, new year, and well, new month, and many have already lightened up on any hard core resolutions, plans, or difficult-to-reach goals.
Walgreens Boots Alliance profits dipped in the company’s fiscal first quarter as the company works to reinvent its U. S. drugstores amid rumors the the global chain may be taken private in a massive leveraged buyout.